298 related articles for article (PubMed ID: 37101169)
1. Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera.
Tseng YL; Lu PC; Lee CC; He RY; Huang YA; Tseng YC; Cheng TR; Huang JJ; Fang JM
J Biomed Sci; 2023 Apr; 30(1):27. PubMed ID: 37101169
[TBL] [Abstract][Full Text] [Related]
2. Human Ubiquilin 2 and TDP-43 copathology drives neurodegeneration in transgenic Caenorhabditis elegans.
Saxton AD; Kraemer BC
G3 (Bethesda); 2021 Aug; 11(8):. PubMed ID: 33963840
[TBL] [Abstract][Full Text] [Related]
3. TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
Montalbano M; McAllen S; Cascio FL; Sengupta U; Garcia S; Bhatt N; Ellsworth A; Heidelman EA; Johnson OD; Doskocil S; Kayed R
Neurobiol Dis; 2020 Dec; 146():105130. PubMed ID: 33065281
[TBL] [Abstract][Full Text] [Related]
4. TDP-43 neurotoxicity and protein aggregation modulated by heat shock factor and insulin/IGF-1 signaling.
Zhang T; Mullane PC; Periz G; Wang J
Hum Mol Genet; 2011 May; 20(10):1952-65. PubMed ID: 21355045
[TBL] [Abstract][Full Text] [Related]
5. The tau tubulin kinases TTBK1/2 promote accumulation of pathological TDP-43.
Liachko NF; McMillan PJ; Strovas TJ; Loomis E; Greenup L; Murrell JR; Ghetti B; Raskind MA; Montine TJ; Bird TD; Leverenz JB; Kraemer BC
PLoS Genet; 2014 Dec; 10(12):e1004803. PubMed ID: 25473830
[TBL] [Abstract][Full Text] [Related]
6. Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation.
French RL; Grese ZR; Aligireddy H; Dhavale DD; Reeb AN; Kedia N; Kotzbauer PT; Bieschke J; Ayala YM
J Biol Chem; 2019 Apr; 294(17):6696-6709. PubMed ID: 30824544
[TBL] [Abstract][Full Text] [Related]
7. Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies.
Cascella R; Capitini C; Fani G; Dobson CM; Cecchi C; Chiti F
J Biol Chem; 2016 Sep; 291(37):19437-48. PubMed ID: 27445339
[TBL] [Abstract][Full Text] [Related]
8. Znf179 E3 ligase-mediated TDP-43 polyubiquitination is involved in TDP-43- ubiquitinated inclusions (UBI) (+)-related neurodegenerative pathology.
Lee YC; Huang WC; Lin JH; Kao TJ; Lin HC; Lee KH; Lin HC; Shen CJ; Chang WC; Huang CC
J Biomed Sci; 2018 Nov; 25(1):76. PubMed ID: 30404641
[TBL] [Abstract][Full Text] [Related]
9. TAR DNA-binding protein 43 oligomers in physiology and pathology.
Lye YS; Chen YR
IUBMB Life; 2022 Aug; 74(8):794-811. PubMed ID: 35229461
[TBL] [Abstract][Full Text] [Related]
10. Hyperphosphorylation as a defense mechanism to reduce TDP-43 aggregation.
Li HY; Yeh PA; Chiu HC; Tang CY; Tu BP
PLoS One; 2011; 6(8):e23075. PubMed ID: 21850253
[TBL] [Abstract][Full Text] [Related]
11. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration.
Wegorzewska I; Bell S; Cairns NJ; Miller TM; Baloh RH
Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18809-14. PubMed ID: 19833869
[TBL] [Abstract][Full Text] [Related]
12. A high-content screen identifies novel compounds that inhibit stress-induced TDP-43 cellular aggregation and associated cytotoxicity.
Boyd JD; Lee P; Feiler MS; Zauur N; Liu M; Concannon J; Ebata A; Wolozin B; Glicksman MA
J Biomol Screen; 2014 Jan; 19(1):44-56. PubMed ID: 24019256
[TBL] [Abstract][Full Text] [Related]
13. Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43).
Shodai A; Morimura T; Ido A; Uchida T; Ayaki T; Takahashi R; Kitazawa S; Suzuki S; Shirouzu M; Kigawa T; Muto Y; Yokoyama S; Takahashi R; Kitahara R; Ito H; Fujiwara N; Urushitani M
J Biol Chem; 2013 May; 288(21):14886-905. PubMed ID: 23558684
[TBL] [Abstract][Full Text] [Related]
14. Neurotoxic effects of TDP-43 overexpression in C. elegans.
Ash PE; Zhang YJ; Roberts CM; Saldi T; Hutter H; Buratti E; Petrucelli L; Link CD
Hum Mol Genet; 2010 Aug; 19(16):3206-18. PubMed ID: 20530643
[TBL] [Abstract][Full Text] [Related]
15. Partial Failure of Proteostasis Systems Counteracting TDP-43 Aggregates in Neurodegenerative Diseases.
Cascella R; Fani G; Bigi A; Chiti F; Cecchi C
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357627
[TBL] [Abstract][Full Text] [Related]
16. Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis.
Smethurst P; Risse E; Tyzack GE; Mitchell JS; Taha DM; Chen YR; Newcombe J; Collinge J; Sidle K; Patani R
Brain; 2020 Feb; 143(2):430-440. PubMed ID: 32040555
[TBL] [Abstract][Full Text] [Related]
17. Praja1 RING-finger E3 ubiquitin ligase suppresses neuronal cytoplasmic TDP-43 aggregate formation.
Watabe K; Kato Y; Sakuma M; Murata M; Niida-Kawaguchi M; Takemura T; Hanagata N; Tada M; Kakita A; Shibata N
Neuropathology; 2020 Dec; 40(6):570-586. PubMed ID: 32686212
[TBL] [Abstract][Full Text] [Related]
18. Reduced protein turnover mediates functional deficits in transgenic mice expressing the 25 kDa C-terminal fragment of TDP-43.
Caccamo A; Shaw DM; Guarino F; Messina A; Walker AW; Oddo S
Hum Mol Genet; 2015 Aug; 24(16):4625-35. PubMed ID: 26002100
[TBL] [Abstract][Full Text] [Related]
19. Maple Syrup Decreases TDP-43 Proteotoxicity in a Caenorhabditis elegans Model of Amyotrophic Lateral Sclerosis (ALS).
Aaron C; Beaudry G; Parker JA; Therrien M
J Agric Food Chem; 2016 May; 64(17):3338-44. PubMed ID: 27071850
[TBL] [Abstract][Full Text] [Related]
20. TDP-1/TDP-43 potentiates human α-Synuclein (HASN) neurodegeneration in Caenorhabditis elegans.
Shen L; Wang C; Chen L; Leung KL; Lo E; Lakso M; Wong G
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165876. PubMed ID: 32531261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
